Covalon Technologies Ltd.
CVALF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$114.06M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $114.06 Million |
|---|---|
| Enterprise Value | $96.36 Million |
| Annual dividend | $0.11 |
| Dividend yield | 3.63% |
| Earnings per Share | $0.08 |
| Beta | 0.03 |
| Outstanding Shares | 27,618,077 |
Return
| Return on Equity | 13.91% |
|---|---|
| Return on Assets | 12.00% |
| Return on Invested Capital | 12.00% |
Valuation & Multiples
| P/E Ratio | 26.26 |
|---|---|
| PEG | 0.62 |
| Price to Sales | 3.02 |
| Price to Book Ratio | 3.02 |
| Enterprise Value to Revenue | 2.8 |
| Enterprise Value to EBIT | 24.4 |
| Enterprise Value to Net Income | 21 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 27, 2026
EPS Estimate
$0.01
Consensus analyst estimateRevenue Estimate
$6.65 M
Consensus analyst estimateNext Earnings Call
Expected Date
December 10, 2026
EPS Estimate
$0.03
Consensus analyst estimateRevenue Estimate
$7.10 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Covalon Technologies Ltd.
105 employees
CEO: Brent Ashton
Covalon Technologies Ltd., a Canadian company based in Mississauga, innovates, develops, manufactures, and commercializes medical technologies and products globally. Its operations span major international markets, including North Americ...